Pulmonary Medicine
Follow @pulmmed_ce on Twitter for the latest expert-led education by serialized tweetorial!
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Multidimensional, Serial Risk Assessment in PAH: How, Why, and Then What to Individualize Goal-Directed Therapy
1b) @AlbertaPHdoc from #Edmonton will be discussing Serial, Multidimensional #RiskAssessment in #PAH: How, Why, and Then What to Individualize...
Current Treatment Guidelines Concerning First-Line Therapy for ES-SCLC and Clinical Trial Review for New and Emerging Treatments
1b) Be sure to check out (and earn even MORE 🆓CE/#CME credit from my colleague @PatelOncology 's introduction to contemporary #ES_SCLC...
Implementing Optimal First-Line Treatment of Patients with ES-SCLC
2a) I am Dr. Sandip Patel @PatelOncology, Professor in Medical Oncology from @UCSDCancer. @nicogirardcurie (to follow) and I will be covering...
BRONCHIECTASIS CASE-BASED LEARNING
2) I am very excited to be among the founding faculty in this initiative! FOLLOW US for awesome expert-led education #pulmtwitter!👍@BronchiectasisR...
ESMO-IO 22: Biomarker-Driven Therapeutics for NSCLC
2) I am Dr. Aakash Desai (@ADesaiMD) from @MayoHemOnc @MayoCancerCare @HemOncFellows @Oncoalert and now we are covering @myESMO #ESMOImmuno22...
Update on Guidelines-Based Management of COPD Exacerbations
2) This program is intended for #healthcare providers and is supported by an educational grant from GSK plc. Statement of accreditation &...
UPDATE on CTEPH
2) I am Jason Weatherald @AlbertaPHdoc of @UAlberta and you may recall my previous tweetorial in this feed. It's still available for credit at...
ESMO22: Updates on ADCs in Development for Lung Cancer
2) Now we are covering @myESMO #ESMO22 updates on #ADCs in development for #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD)...
ESMO22 Updates on HER2 Mutant Lung Cancer
2) In this program we are covering @myESMO #ESMO22 updates on #HER2 mutant #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD)...
Diagnosis and Management of Pulmonary Hypertension
2) This program is supported by educational grants from Actelion, AstraZeneca, and Bayer, and is intended for healthcare professionals. Statement of...
@pulmmed_ce on Twitter
Your only source for ACCREDITED SoMe-delivered serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!